Approximately, USD

Approximately USD 10.8 Million Invested in New Drug Development for Malaria and NTDs in Partners Including Japanese Pharma Shionogi, Mitsubishi Tanabe, and Eisai and Europe-Based Institutions

Veröffentlicht: 07.08.2025 um 18:07 Uhr, prnewswire.co.uk

Global Health Innovative Technology Fund (GHIT Fund) Japan

View original content:https://www.prnewswire.co.uk/news-releases/approximately-usd-10-8-million-invested-in-new-drug-development-for-malaria-and-ntds-in-partners-including-japanese-pharma-shionogi-mitsubishi-tanabe-and-eisai-and-europe-based-institutions-302140124.html

en | boerse | 67939069 |